US health department to allow temporary sale of some unapproved peptides Reuters
US health department to allow temporary sale of some unapproved peptides - Reuters
In short
The United States health department will permit the temporary sale of specific peptide products that lack formal authorization. Regulators are introducing this measure to authorize market distribution on an interim basis. The agency will monitor product availability as the provisional policy takes effect across the country.
Key points
- Federal authorities have agreed to facilitate the interim commercial availability of thes…: Federal authorities have agreed to facilitate the interim commercial availability of these substances.
- Regulatory flexibility from the health department will temporarily open consumer access t…: Regulatory flexibility from the health department will temporarily open consumer access to peptides.
- Health officials will oversee the short-term marketplace availability for these designate…: Health officials will oversee the short-term marketplace availability for these designated compounds.